1.
Sekeres MA, Lancet JE, Wood BL, Grove LE, Sandalic L, Sievers EL, Jurcic JG. Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia. Haematologica [Internet]. 2012Dec.31 [cited 2026Nov.14];98(1):119-28. Available from: https://haematologica.org/article/view/6524